RL
Rallybio
RLYB·NASDAQNew Haven CTFounded 201860 employees
Micro CapbiotechPublicHematologyRare Disease
Platform: Anti-HPA FNAIT
Market Cap
$0.1B
All Drugs
2
Clinical Trials
6
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (RLYB)
Loading RLYB stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| RLY-4615 | RLY-4615 | Phase 3 | 4 | PD-1 | Prostate Ca | ||
| RLY-2544 | RLY-2544 | Preclinical | 2 | FLT3 | CRCPsoriasis |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (5)